Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib

BACKGROUND: Despite reported advances, acquired resistance to tyrosine kinase inhibitors still represents a serious problem in successful cancer treatment. Among this class of drugs, ponatinib (PON) has been shown to have notable long-term efficacy, although its cytotoxicity might be hampered by aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Corallo, Diana, Pastorino, Fabio, Pantile, Marcella, Mariotto, Elena, Caicci, Federico, Viola, Giampietro, Ponzoni, Mirco, Tonini, Gian Paolo, Aveic, Sanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507635/
https://www.ncbi.nlm.nih.gov/pubmed/32962733
http://dx.doi.org/10.1186/s13046-020-01692-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507635/
https://www.ncbi.nlm.nih.gov/pubmed/32962733
http://dx.doi.org/10.1186/s13046-020-01692-x

Ejemplares similares